Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 8279
TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239057BDBM239057(US9408863, 13)
Affinity DataEC50:  3.50E+3nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239046BDBM239046(US9408863, 2)
Affinity DataEC50:  1.00E+4nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239056BDBM239056(US9408863, 12)
Affinity DataEC50:  1.40E+4nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239052BDBM239052(US9408863, 8)
Affinity DataEC50:  3.80E+4nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239050BDBM239050(US9408863, 6)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239051BDBM239051(US9408863, 7)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239048BDBM239048(US9408863, 4)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239049BDBM239049(US9408863, 5)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239047BDBM239047(US9408863, 3)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239045BDBM239045(US9408863, 1)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239054BDBM239054(US9408863, 10)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239055BDBM239055(US9408863, 11)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 239053BDBM239053(US9408863, 9)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2017
Entry Details
US Patent